Peritoneovenous shunt for refractory ascites: operative complications and long-term results
R. A. Bernhoft, C. A. Pellegrini and L. W. Way
We studied the clinical course of 35 patients with refractory ascites who
underwent 51 peritoneovenous shunts. Nine of them had hepatorenal syndrome
(HRS). Operative complications included shunt malfunction, shunt infection,
ascitic leak, fluid overload, and disseminated intravascular coagulation.
Two of the patients without HRS died postoperatively. The survival rate in
this group was 67% at one year and 43% at two years. Ascites was completely
controlled in 83% of the survivors at two months and 50% at two years.
Neither survival nor shunt patency were predictable. The shunt reversed HRS
in three patients, but failed to do so in the other six. Late complications
included shunt malfunction and infection. During the first two years of
follow-up, five patients bled from esophageal varices. Liver failure was
the sole cause of late death. Peritoneovenous shunt should be reserved for
patients with truly refractory ascites, for whom it provides excellent
palliation.
